Wacker Biotech Discovery Award

Wacker Biotech B.V. - Amsterdam Life Sciences District

The Wacker Biotech Discovery Award recognizes life sciences startups and entrepreneurs who are driving scientific innovation by developing pDNA and/or mRNA-based therapeutics and biopharmaceutical technologies.

The winner of the Wacker Biotech Discovery Award shall receive:

  • in-kind credits (valued at $100,000) to work with Wacker Biotech
  • invitation to pitch at the CLS Innovation Showcase taking place December 10, 2024. Learn more details about the CLS Innovation Showcase here.

How To Apply

Your non-confidential application should highlight:

  • Your innovative approach
  • How your technology aligns with Wacker Biotech’s focus areas
  • How your company could benefit from advancing your programs with Wacker Biotech’s.

Timeline:

  • July 1, 2024: Application due date
  • November 15, 2024: Wacker Biotech Discovery Award announced
  • December 10, 2024: Innovation Showcase (Bay Area)

Disclosure:

The winner of the Wacker Biotech Discovery Award will be fast-tracked to pitch at the CLS Innovation Showcase taking place December 10, 2024. A representative from Wacker Biotech shall contact the awardee to discuss availing in-kind credits.

APPLY HERE»

Any questions or comments can be directed to Shikha Sharma at [email protected].

About Wacker Biotech

Wacker Biotech B.V. - Amsterdam Life Sciences District

Wacker Biotech is your CDMO partner for the entire manufacturing chain of plasmid DNA (pDNA) and messenger RNA (mRNA) to lipid nanoparticle (LNP) formulations. We leverage our global team of development, process engineering, and manufacturing experts and a network of state-of-the-art facilities to accelerate our partners’ programs from research phase to the market. For more information, visit www.wacker.com.